Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
(PHN Trial)
Recruiting in Palo Alto (17 mi)
+52 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Zalicus
Prior Safety Data
Trial Summary
What is the purpose of this trial?
This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.
Research Team
Eligibility Criteria
Inclusion Criteria
Provide written informed consent.
Either sex but must be aged >=18 years.
Diagnosis of PHN as defined by the presence of pain in the area affected by herpes zoster >=6 months after the herpes zoster skin rash has healed.
See 3 more
Treatment Details
Interventions
- Placebo (Other)
- Z160 (Other)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Z160Experimental Treatment1 Intervention
375 mg BID
Group II: PlaceboPlacebo Group1 Intervention
matching placebo control
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Investigative SiteColorado Springs, CO
Investigative SiteChandler, AZ
Investigative SitePhoenix, AZ
Investigative SiteLos Angeles, CA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Zalicus
Lead Sponsor
Trials
12
Patients Recruited
1,200+